These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Neuromyelitis optica-IgG in idiopathic inflammatory demyelinating disorders amongst Hong Kong Chinese. Chan KH; Ramsden DB; Yu YL; Kwok KH; Chu AC; Ho PW; Kwan JS; Lee R; Lim E; Kung MH; Ho SL Eur J Neurol; 2009 Mar; 16(3):310-6. PubMed ID: 19138340 [TBL] [Abstract][Full Text] [Related]
13. Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder Patients in Turkish Cohort: Demographic, Clinical, and Laboratory Features. Altintas A; Karabudak R; Balci BP; Terzi M; Soysal A; Saip S; Tuncer Kurne A; Uygunoglu U; Nalbantoglu M; Gozubatik Celik G; Isik N; Celik Y; Gokcay F; Duman T; Boz C; Yucesan C; Mangan MS; Celebisoy N; Diker S; Colpak Isikay I; Kansu T; Siva A Neurologist; 2015 Oct; 20(4):61-6. PubMed ID: 26468870 [TBL] [Abstract][Full Text] [Related]
14. Utility of aquaporin-4 antibody assay in patients with neuromyelitis optica spectrum disorders. Kim SM; Waters P; Woodhall M; Kim JY; Kim JE; Yang JW; Kim JS; Sung JJ; Park KS; Lee KW Mult Scler; 2013 Jul; 19(8):1060-7. PubMed ID: 23329699 [TBL] [Abstract][Full Text] [Related]
15. Brain and spinal cord lesion criteria distinguishes AQP4-positive neuromyelitis optica and MOG-positive disease from multiple sclerosis. Bensi C; Marrodan M; González A; Chertcoff A; Osa Sanz E; Chaves H; Schteinschnaider A; Correale J; Farez MF Mult Scler Relat Disord; 2018 Oct; 25():246-250. PubMed ID: 30144694 [TBL] [Abstract][Full Text] [Related]
16. Significance of gray matter brain lesions in multiple sclerosis and neuromyelitis optica. Kawachi I; Nishizawa M Neuropathology; 2015 Oct; 35(5):481-6. PubMed ID: 26079808 [TBL] [Abstract][Full Text] [Related]
17. Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay. Hayakawa S; Mori M; Okuta A; Kamegawa A; Fujiyoshi Y; Yoshiyama Y; Mitsuoka K; Ishibashi K; Sasaki S; Hattori T; Kuwabara S J Neuroimmunol; 2008 May; 196(1-2):181-7. PubMed ID: 18462810 [TBL] [Abstract][Full Text] [Related]
18. Immunopathogenesis of neuromyelitis optica. Levy M; Wildemann B; Jarius S; Orellano B; Sasidharan S; Weber MS; Stuve O Adv Immunol; 2014; 121():213-42. PubMed ID: 24388217 [TBL] [Abstract][Full Text] [Related]
19. The prevalence of long spinal cord lesions and anti-aquaporin 4 antibodies in neuromyelitis optica patients in Taiwan. Wang KC; Tsai CP; Lee CL; Chen SY; Chen SJ Eur Neurol; 2011; 65(2):99-104. PubMed ID: 21273778 [TBL] [Abstract][Full Text] [Related]
20. Recent insights into the pathology of multiple sclerosis and neuromyelitis optica. Wegner C Clin Neurol Neurosurg; 2013 Dec; 115 Suppl 1():S38-41. PubMed ID: 24321153 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]